- Issuer ticker
-
AXSM
- Reported as of
-
06 Jun 2025
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
10 Jun 2025, 19:00:19 UTC
Filing notes and source
Key filing fact
Roger Jeffs filed Form 4 for Axsome Therapeutics, Inc. (AXSM) on 10 Jun 2025.
Key facts
- This page summarizes Roger Jeffs's Form 4 filing for Axsome Therapeutics, Inc. (AXSM).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 10 Jun 2025, 19:00.
Change
- Previous filing in this sequence was filed on 05 Jun 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001231615
Primary reporting owner
JEFFS ROGER
- Relationship
-
Director
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AXSM
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +3,166
- Change %
- Price
-
$0.000000
- Shares after
- 3,166
- Date
- 06 Jun 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,166
- Exercise price
- $111.91
- Footnotes
- F1
AXSM
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +1,429
- Change %
- Price
-
$0.000000
- Shares after
- 1,429
- Date
- 06 Jun 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,429
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Explanation of responses
3 footnotes